Lishan Aklog

Insider Reports History

Location: 420 Lexington Avenue, Suite 300, New York, NY
Signature: /s/ Michael A. Gordon, by power of attorney
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Lucid Diagnostics Inc.	Chief Executive Officer, Director	Common Stock	1.47M	$2.06M	$1.40	Feb 20, 2025	Direct
CONTRAFECT Corp	Director	Options (Right to Buy)	42K	$141K	$3.35	May 17, 2022	Direct
PAVmed Inc.	Chairman and CEO, Director	Common Stock	297K	$131K	$0.44	Sep 30, 2025	By Pavilion Venture Partners LLC
PAVmed Inc.	Chairman and CEO, Director	Common Stock	228K	$101K	$0.44	Sep 30, 2025	Direct
PAVmed Inc.	Chairman and CEO, Director	Common Stock	1.33K	$586	$0.44	Sep 30, 2025	By HCFP/AG LLC
PAVmed Inc.	Chairman and CEO, Director	Common Stock	154	$67.00	$0.44	Sep 30, 2025	By daughter
PAVmed Inc.	Chairman and CEO, Director	Common Stock	152	$66.00	$0.44	Sep 30, 2025	By son

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
PAVM	PAVmed Inc.	Sep 30, 2025	1	$0	4	Oct 2, 2025	Chairman and CEO, Director
LUCD	Lucid Diagnostics Inc.	Feb 20, 2025	1	$0	4	Feb 21, 2025	Chief Executive Officer, Director
LUCD	Lucid Diagnostics Inc.	May 7, 2024	1	$0	4	May 8, 2024	Chief Executive Officer, Director
CFRX	CONTRAFECT Corp	May 17, 2022	1	$141K	4	May 18, 2022	Director
PAVM	PAVmed Inc.	Mar 28, 2022	1	-$94K	4	Apr 11, 2022	Chairman and CEO, Director
LUCD	Lucid Diagnostics Inc.	Feb 18, 2022	1	$0	4	Feb 23, 2022	Chief Executive Officer, Director
PAVM	PAVmed Inc.	Feb 18, 2022	1	$0	4	Feb 23, 2022	Chairman and CEO, Director, 10%+ Owner
LUCD	Lucid Diagnostics Inc.	Jan 7, 2022	1	$0	4	Jan 10, 2022	Chief Executive Officer, Director
LUCD	Lucid Diagnostics Inc.	Oct 13, 2021	0	$0	3	Oct 13, 2021	Chief Executive Officer, Director
CFRX	CONTRAFECT Corp	May 18, 2021	1	$0	4	May 20, 2021	Director